Acutus Medical (NASDAQ:AFIB – Get Free Report) and Stevanato Group (NYSE:STVN – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, earnings and institutional ownership.
Insider and Institutional Ownership
56.9% of Acutus Medical shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by company insiders. Comparatively, 0.7% of Stevanato Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Earnings and Valuation
This table compares Acutus Medical and Stevanato Group”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Acutus Medical | $7.16 million | 0.21 | -$81.66 million | N/A | N/A |
| Stevanato Group | $1.09 billion | 5.80 | $157.62 million | €0.47 ($0.49) | 44.57 |
Risk & Volatility
Acutus Medical has a beta of -0.18, indicating that its stock price is 118% less volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500.
Profitability
This table compares Acutus Medical and Stevanato Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Acutus Medical | -272.74% | -311.64% | -11.57% |
| Stevanato Group | 10.47% | 9.86% | 5.79% |
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Acutus Medical and Stevanato Group, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Acutus Medical | 0 | 0 | 0 | 0 | 0.00 |
| Stevanato Group | 0 | 1 | 5 | 0 | 2.83 |
Summary
Stevanato Group beats Acutus Medical on 9 of the 11 factors compared between the two stocks.
About Acutus Medical
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
About Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Receive News & Ratings for Acutus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acutus Medical and related companies with MarketBeat.com's FREE daily email newsletter.
